{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:58:33Z","timestamp":1788299913755,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Suitable Medical and Health Technology Research in Developmental Projects of Guangxi","award":["S201516"],"award-info":[{"award-number":["S201516"]}]},{"name":"a Project of the Guangxi Province Education Commission of the Teacher Foundation for Youths","award":["KY2016YB085"],"award-info":[{"award-number":["KY2016YB085"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To determine the standard remnant liver volume (SRLV) threshold to avoid postoperative hepatic insufficiency inpatients in different stages of hepatic fibrosis who undergo right hemi-hepatectomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data for 85 patients at our single medical center were analysed prospectively to examine whether the following factors differed significantly between those who experienced postoperative hepatic insufficiency and those who did not: height, prothrombin time, remnant liver volume, SRLV or hepatic fibrosis stage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Logistic regression showed SRLV and hepatic fibrosis stage to be independent risk factors for postoperative hepatic insufficiency. The threshold SRLV for predicting insufficiency was 203.2\u00a0ml\/m<jats:sup>2<\/jats:sup> across all patients [area under receiver operating characteristic curve (AUC) 0.778, sensitivity 66.67%, specificity 83.64%, p&lt;0.0001), 193.8\u00a0ml\/m<jats:sup>2<\/jats:sup> for patients with severe hepatic fibrosis (AUC 0.938, sensitivity 91.30%, specificity 85.71%, p&lt;0.0001), and 224.3\u00a0ml\/m<jats:sup>2<\/jats:sup> for patients with cirrhosis (AUC 0.888, sensitivity 100%, specificity 64.29%, p&lt;0.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Right hemi-hepatectomy may be safer in Chinese patients when the standard remnant liver volume is more than 203.2\u00a0ml\/m<jats:sup>2<\/jats:sup> in the absence of hepatic fibrosis or cirrhosis, 193.8\u00a0ml\/m<jats:sup>2<\/jats:sup> in the presence of severe hepatic fibrosis or 224.3\u00a0ml\/m<jats:sup>2<\/jats:sup> in the presence of cirrhosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-021-01065-x","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T07:03:33Z","timestamp":1611385413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhiming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoxiong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-1192","authenticated-orcid":false,"given":"Lequn","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"issue":"13","key":"1065_CR1","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.3748\/wjg.v21.i13.3826","volume":"21","author":"HJ Yim","year":"2015","unstructured":"Yim HJ, Suh SJ, Um SH. Current management of hepatocellular carcinoma: an Eastern perspective. World J Gastroenterol. 2015;21(13):3826\u201342.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1065_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.suronc.2016.03.002","volume":"25","author":"MS Grandhi","year":"2016","unstructured":"Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, Kamel IR, Ghasebeh MA, Pawlik TM. Hepatocellular carcinoma: from diagnosis to treatment. Surg Oncol. 2016;25(2):74\u201385.","journal-title":"Surg Oncol"},{"key":"1065_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-3-319-34244-3_8","volume":"168","author":"O Kantor","year":"2016","unstructured":"Kantor O, Baker MS. Hepatocellular carcinoma: surgical management and evolving therapies. Cancer Treat Res. 2016;168:165\u201383.","journal-title":"Cancer Treat Res"},{"issue":"1","key":"1065_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejso.2016.05.026","volume":"43","author":"GK Glantzounis","year":"2017","unstructured":"Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg. 2017;43(1):32\u201341.","journal-title":"Eur J Surg"},{"issue":"6","key":"1065_CR5","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s11605-017-3389-y","volume":"21","author":"E Sparrelid","year":"2017","unstructured":"Sparrelid E, Jonas E, Tzortzakakis A, Dahl\u00e9n U, Murquist G, Brismar T, et al. Dynamic evaluation of liver volume and function in associating liver partition and portal vein ligation for staged hepatectomy. J Gastrointest Surg. 2017;21(6):967\u201374.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"1065_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jamcollsurg.2016.01.060","volume":"223","author":"D Ribero","year":"2016","unstructured":"Ribero D, Zimmitti G, Aloia TA, Shindoh J, Fabio F, Amisano M, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg. 2016;223(1):87\u201397.","journal-title":"J Am Coll Surg"},{"issue":"3","key":"1065_CR7","first-page":"189","volume":"48","author":"ZG Du","year":"2010","unstructured":"Du ZG, Li B, Feng X, Yin J, Yan LN, Wen TF, et al. Combined indocyanine green test and standard remnant liver volume to predict post-hepatectomy hepatic insufficiency for the patients with hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi. 2010;48(3):189\u201392.","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"3","key":"1065_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1072-7515(98)00301-9","volume":"188","author":"K Shirabe","year":"1999","unstructured":"Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188(3):304\u20139.","journal-title":"J Am Coll Surg"},{"issue":"7","key":"1065_CR9","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1007\/s00330-016-4648-0","volume":"27","author":"PJ Pickhardt","year":"2017","unstructured":"Pickhardt PJ, Malecki K, Hunt OF, Beaumont C, Kloke J, Ziemlewicz TJ, et al. Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis. Eur Radiol. 2017;27(7):3060\u20138.","journal-title":"Eur Radiol"},{"issue":"4","key":"1065_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","volume":"151","author":"Z Lei","year":"2016","unstructured":"Lei Z, Li J, Wu D, Xia Y, Wang Q, Si A, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg. 2016;151(4):356\u201363.","journal-title":"JAMA Surg"},{"issue":"17","key":"1065_CR11","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1097\/MD.0000000000000784","volume":"94","author":"J Li","year":"2015","unstructured":"Li J, Lei B, Nie X, Lin L, Tahir SA, Shi W, et al. A comprehensive method for predicting fatal liver failure of patients with liver cancer resection. Medicine. 2015;94(17):e784.","journal-title":"Medicine"},{"issue":"5","key":"1065_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","volume":"149","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713\u201324.","journal-title":"Surgery"},{"issue":"17","key":"1065_CR13","doi-asserted-by":"publisher","first-page":"28641","DOI":"10.18632\/oncotarget.16162","volume":"8","author":"Q Li","year":"2017","unstructured":"Li Q, Lu C, Li W, Huang Y, Chen L. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease. Oncotarget. 2017;8(17):28641\u20139.","journal-title":"Oncotarget"},{"issue":"2","key":"1065_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cld.2015.01.007","volume":"19","author":"ME Akoad","year":"2015","unstructured":"Akoad ME, Pomfret EA. Surgical resection and liver transplantation for hepatocellular carcinoma. Clin Liver Dis. 2015;19(2):381\u201399.","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"1065_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/liv.12713","volume":"35","author":"M Colombo","year":"2015","unstructured":"Colombo M, Sangiovanni A. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 2015;35(Suppl 1):129\u201338.","journal-title":"Liver Int"},{"issue":"6","key":"1065_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","volume":"242","author":"S Balzan","year":"2005","unstructured":"Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The \u201c50\u201350 criteria\u201d on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242(6):824\u20138, discussion 8-9.","journal-title":"Ann Surg."},{"issue":"3","key":"1065_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2214\/AJR.16.16450","volume":"208","author":"A Cho","year":"2017","unstructured":"Cho A, Chung YE, Choi JS, Kim KS, Choi GH, Park YN, et al. Feasibility of preoperative FDG PET\/CT total hepatic glycolysis in the remnant liver for the prediction of postoperative liver function. AJR Am J Roentgenol. 2017;208(3):624\u201331.","journal-title":"AJR Am J Roentgenol"},{"issue":"48","key":"1065_CR18","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.3748\/wjg.v18.i48.7327","volume":"18","author":"ZR Shi","year":"2012","unstructured":"Shi ZR, Yan LN, Du CY. Donor safety and remnant liver volume in living donor liver transplantation. World J Gastroenterol. 2012;18(48):7327\u201332.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"1065_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","volume":"138","author":"G Maldonado","year":"1993","unstructured":"Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923\u201336.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"1065_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jhep.2008.04.019","volume":"49","author":"A Myronovych","year":"2008","unstructured":"Myronovych A, Murata S, Chiba M, Matsuo R, Ikeda O, Watanabe M, et al. Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol. 2008;49(3):363\u201372.","journal-title":"J Hepatol"},{"issue":"8","key":"1065_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/lt.23450","volume":"18","author":"S Gruttadauria","year":"2012","unstructured":"Gruttadauria S, Parikh V, Pagano D, Tuzzolino F, Cintorino D, Miraglia R, et al. Early regeneration of the remnant liver volume after right hepatectomy for living donation: a multiple regression analysis. Liver Transpl. 2012;18(8):907\u201313.","journal-title":"Liver Transpl"},{"issue":"1","key":"1065_CR22","first-page":"29","volume":"5","author":"C Dorn","year":"2012","unstructured":"Dorn C, Heilmann J, Hellerbrand C. Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. Int J Clin Exp Pathol. 2012;5(1):29\u201336.","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"1065_CR23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/mnfr.201100374","volume":"55","author":"CC Chan","year":"2011","unstructured":"Chan CC, Cheng LY, Lin CL, Huang YH, Lin HC, Lee FY. The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury. Mol Nutr Food Res. 2011;55(12):1841\u20139.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"1065_CR24","doi-asserted-by":"publisher","first-page":"13074","DOI":"10.1038\/s41598-018-31351-3","volume":"8","author":"GX Ouyang","year":"2018","unstructured":"Ouyang GX, Zhang YM, Zhu SL, Wang P, Ren Y, Li JH, et al. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Sci Rep. 2018;8(1):13074.","journal-title":"Sci Rep"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-021-01065-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12893-021-01065-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-021-01065-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T07:09:27Z","timestamp":1611385767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-021-01065-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1186\/s12893-021-01065-x","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"9 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Guangxi Medical University Cancer Hospital (approval LW2019052). Written informed consent was obtained from a legally authorised representative(s) for anonymised patient information to be published in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state that there are no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}